755 (Temozolomide 180 mg)
Pill with imprint 755 is Orange & White, Capsule-shape and has been identified as Temozolomide 180 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..
Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 755
Temozolomide
- Imprint
- 755
- Strength
- 180 mg
- Color
- Orange & White
- Size
- 21.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 68382-0755
- Inactive Ingredients
-
alcohol, ammonia, lactose anhydrous, butyl alcohol, ferric oxide red, ferric oxide yellow, ferrosoferric oxide, gelatin, isopropyl alcohol, potassium hydroxide, propylene glycol, shellac, silicon dioxide, sodium lauryl sulfate, sodium starch glycolate type B potato, stearic acid, tartaric acid, titanium dioxide, water
Note: Inactive ingredients may vary.
Related Images for "755"
More about temozolomide
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 9 Reviews
- Drug class: alkylating agents
Consumer resources
- Temozolomide
- Temozolomide Capsules
- Temozolomide Injection
- Temozolomide (Advanced Reading)
- Temozolomide Intravenous (Advanced Reading)
Other brands: Temodar
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
